Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.25
Bid: 34.25
Ask: 35.45
Change: -1.075 (-2.99%)
Spread: 1.20 (3.504%)
Open: 36.00
High: 36.00
Low: 34.00
Prev. Close: 35.925
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: H&T Group, China Medical, Fyffes...

Wed, 13th May 2009 09:20

Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for the current year but remains conscious of the current difficult economic climate."The principal reason for the strong performance is the sustained gold price which has benefitted the Group's retail sales, auctions, scrap and gold purchases. The Group is also pleased with the continuing success of the store expansion programme," said H&T.Chinese pharmaceutical sales, marketing & research firm China Medical saw pre-tax profit rise to $19.5m from $10.3m before on sales 40% to $72.6m. Total dividend for year will be $0.15p share against $0.10p each. "I am delighted to report on a second outstanding year for CMS as a public company despite the challenging economic environment seen domestically and globally. We have achieved sustained and steady growth in sales and profits, and I am pleased that," said the group.Fruit importer and distributor Fyffes said trading in teh year to date has been in line with expectations and it remains on course to achieve its earnings target for the year. Previously it has taargeted an adjusted EVIB for 2009 in the range of €14m-€18m. Shares in Futura Medical fell back after the consumer healthcare products firm reported a delay in achieving regulatory approval for CSD500, a condom designed to help men maintain an erection.Futura, which is developing the condom with Durex firm SSL, hoped the product would be awarded a CE mark soon after EU authorities expressed a positive opinion on the product's pharmaceutical aspects. However, SSL's decision to move condom manufacturing to Asia means the EU has asked for additional manufacturing data on CSD500 and Futura now expects to receive CE marketing authorisation around the end of the year.Public sector focused support services company Tribal said trading in 2009 has been in line with expectations.The sales pipeline remains healthy while committed income now stands at £210m, up from £139m at the beginning of the year. Printing group Communisis shot up after it announced a contract to T-Mobile UK 's marketing division with a suite of printing services. The contract was awarded to Communisis following a tender process. Housebuilder McInerney said trading conditions during 2009 in its key markets of Ireland and UK continue to be challenging due to low consumer confidence, restricted access to mortgages and the uncertain financial climate."We remain focused on generating positive cash flow and the implementation of additional efficiencies in the Group's cost base. Management's key objective is to rebuild shareholder value in the medium term," it said.Shares in Rheochem slipped back down again today after the oil and gas firm released a statement saying it knew of no reason behind its sudden share price rise earlier in the day. The group said the strategic review of its oil and gas assets are still ongoing and no decision has been reached.
More News
23 May 2022 08:52

LONDON MARKET OPEN: Market cheers Moongpig's new gifting foray

(Alliance News) - European equities made a confident start to the new trading week on Monday, for now setting aside the inflation and economic growth worries that have stifled markets in recent weeks and months.

Read more
26 Apr 2022 18:03

TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
23 Mar 2022 15:35

Futura signs up Korean partner for erection gel product

(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to commercialise the company's topical gel-based erectile dysfunction treatment MED3000 in South Korea.

Read more
23 Mar 2022 11:50

Futura Medical shares rise on licensing deal with Menarini Korea

(Alliance News) - Futura Medical PLC shares jumped on Wednesday after the company said it has entered a licensing agreement with A Menarini Korea Ltd or the exclusive rights to commercialise its MED3000 treatment in South Korea.

Read more
20 Dec 2021 21:59

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

Read more
20 Dec 2021 10:46

Futura Medical makes good progress with topical erection gel treatment

(Sharecast News) - Futura Medical updated the market on regulatory and commercial progress for 'MED3000', its topical gel formulation for the treatment of erectile dysfunction, on Monday.

Read more
29 Oct 2021 15:57

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Read more
8 Oct 2021 13:51

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

Read more
29 Sep 2021 13:22

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

Read more
27 Sep 2021 16:54

Futura Medical inks licensing deal with Labtec Pharma

(Sharecast News) - Transdermal drug delivery technology company Futura Medical has entered into a licensing agreement with Labatec Pharma, a Switzerland-based specialty pharma company focussed on commercialisation in the Europe and Middle East and North Africa (MENA) regions, it announced on Monday.

Read more
27 Sep 2021 12:01

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

Read more
22 Sep 2021 17:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
15 Sep 2021 20:23

IN BRIEF: Futura progressing US regulatory submission for MED3000

IN BRIEF: Futura progressing US regulatory submission for MED3000

Read more
1 Sep 2021 20:56

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

Read more
31 Aug 2021 15:08

Futura enters erection gel licensing deal with M8

(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.